2024
ICD-10-CM
Diagnosis
Code

D64.81 Anemia due to antineoplastic chemotherapy

  • Billable
  • 2016–2024

D64.81 is a billable/specific diagnosis code from the 2024 ICD-10-CM used to classify the following condition: Anemia due to antineoplastic chemotherapy.

Inclusion term

  • Antineoplastic chemotherapy induced anemia

Type 2 excludes

  • Anemia in neoplastic disease (D63.0)

  • Aplastic anemia due to antineoplastic chemotherapy (D61.1)

Versions

  1. 2024

    No changes

  2. 2023

    No changes

  3. 2022

    Code changed

    • Type 1 excludes

        • aplastic anemia due to antineoplastic chemotherapy (D61.1)
    • Type 2 excludes

        • anemia in neoplastic disease (D63.0)
        • anemia in neoplastic disease (D63.0)
        • aplastic anemia due to antineoplastic chemotherapy (D61.1)
  4. 2021

    No changes

  5. 2020

    No changes

  6. 2019

    No changes

  7. 2018

    No changes

  8. 2017

    Code changed

    • Type 1 excludes

        • anemia in neoplastic disease (D63.0)
        • aplastic anemia due to antineoplastic chemotherapy (D61.1)
        • aplastic anemia due to antineoplastic chemotherapy (D61.1)
    • Type 2 excludes

        • anemia in neoplastic disease (D63.0)
  9. 2016

    New code